BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 27920477)

  • 21. Pancreatic fat content may increase the risk of imaging progression in low-risk branch duct intraductal papillary mucinous neoplasm.
    Kashiwagi K; Minami K; Seino T; Hirata K; Iwasaki E; Inoue N; Iwao Y; Kanai T
    J Dig Dis; 2019 Oct; 20(10):557-562. PubMed ID: 31322828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
    Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
    Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
    Marchegiani G; Andrianello S; Pollini T; Caravati A; Biancotto M; Secchettin E; Bonamini D; Malleo G; Bassi C; Salvia R
    Am J Gastroenterol; 2019 Oct; 114(10):1678-1684. PubMed ID: 31449158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance cholangiopancreatography with compressed sensing at 1.5 T: clinical application for the evaluation of branch duct IPMN of the pancreas.
    Henninger B; Steurer M; Plaikner M; Weiland E; Jaschke W; Kremser C
    Eur Radiol; 2020 Nov; 30(11):6014-6021. PubMed ID: 32556465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
    Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
    World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidental cystic neoplasms of pancreas: what is the optimal interval of imaging surveillance?
    Das A; Wells CD; Nguyen CC
    Am J Gastroenterol; 2008 Jul; 103(7):1657-62. PubMed ID: 18564119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidental pancreatic cysts: a frequent finding in liver-transplanted patients as assessed by 3D T2-weighted turbo spin echo magnetic resonance cholangiopancreatography.
    Girometti R; Intini SG; Cereser L; Bazzocchi M; Como G; Del Pin M; Baccarani U; Toniutto P; Zuiani C
    JOP; 2009 Sep; 10(5):507-14. PubMed ID: 19734626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does preoperative cross-sectional imaging accurately predict main duct involvement in intraductal papillary mucinous neoplasm?
    Barron MR; Roch AM; Waters JA; Parikh JA; DeWitt JM; Al-Haddad MA; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Pitt HA; Schmidt CM
    J Gastrointest Surg; 2014 Mar; 18(3):447-55; discussion 5455-6. PubMed ID: 24402606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
    Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
    Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.
    Sahani DV; Kadavigere R; Blake M; Fernandez-Del Castillo C; Lauwers GY; Hahn PF
    Radiology; 2006 Feb; 238(2):560-9. PubMed ID: 16436817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraductal papillary tumors of the pancreas: evaluation with magnetic resonance cholangiopancreatography.
    Sugiyama M; Atomi Y; Hachiya J
    Am J Gastroenterol; 1998 Feb; 93(2):156-9. PubMed ID: 9468232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifocal branch-duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: magnetic resonance (MR) imaging pattern and evolution over time.
    Castelli F; Bosetti D; Negrelli R; Di Paola V; Zantedeschi L; Ventriglia A; Manfredi R; Mucelli RP
    Radiol Med; 2013 Sep; 118(6):917-29. PubMed ID: 23801393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
    Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
    Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Branch duct intraductal papillary mucinous neoplasm - contra resection].
    Brunner M; Weber GF; Kersting S; Grützmann R
    Chirurg; 2017 Nov; 88(11):918-926. PubMed ID: 28871376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI findings of intraductal papillary mucinous neoplasms (IPMNs).
    Lana S; Vallara M; Bono NE; Russo G; Artioli G; Capretti G; Paladini I; Pesce A; Ruggirello M; Barbalace S; Mostardi M
    Acta Biomed; 2016 Jul; 87 Suppl 3():28-33. PubMed ID: 27467864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan Pancreas Society multicenter study.
    Kobayashi G; Fujita N; Maguchi H; Tanno S; Mizuno N; Hanada K; Hatori T; Sadakari Y; Yamaguchi T; Tobita K; Doi R; Yanagisawa A; Tanaka M;
    Pancreas; 2014 May; 43(4):532-8. PubMed ID: 24717801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of low-risk branch-duct IPMNs of the pancreas: is main pancreatic duct dilatation the most worrisome feature?
    Petrone MC; Magnoni P; Pergolini I; Capurso G; Traini M; Doglioni C; Mariani A; Crippa S; Arcidiacono PG
    Clin Transl Gastroenterol; 2018 Jun; 9(6):158. PubMed ID: 29895904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.